Dextenza With ILUX for Treatment of MGD

Status Completed

Clinical Trial Summary

To evaluate the benefit of treatment with a physician administered intracanalicular dexamethasone insert in evaporative dry eye disease (DED) patients with meibomian gland disfunction (MGD) and underlying inflammation undergoing iLUX MGD Treatment System.

Clinical Trial Description

This prospective study will use a fellow-eye design for 30 participants, (2 groups of 15) equating to 60 eyes. All eyes will receive bilateral iLUX MGD Treatment System. The most symptomatic eye will be selected to receive DEXTENZA® insertion on the day of the procedure (study eye). In group 1, the other eye will be assigned to receive prednisolone acetate 1% on a 4,3,2,1 month taper schedule (active comparator). In group 2, the other eye will receive punctal "sham" dilation (control eye). If there is no obvious symptomatic difference, the right eye will receive the intracanalicular insert. The study group will consist of 30 eyes receiving DEXTENZA® insertion. The control group will consist of 15 eyes receiving prednisolone acetate 1% and 15 eyes receiving sham punctum dilation. Thus, for every eye in the study group, there will be a paired eye with similar baseline characteristics in the control group sourced from the same participant. This fellow-eye design allows for greater control of potential confounders tied to participants' systemic and ocular health. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04658927
Study type	Interventional
Source	Warrenville Eyecare
Contact
Status	Completed
Phase	Phase 4
Start date	January 4, 2021
Completion date	May 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05062564` - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye	N/A
Completed	`NCT04884243` - Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction	Phase 2
Active, not recruiting	`NCT04425551` - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction	N/A
Terminated	`NCT02596919` - Fast Infrared Meibography (Photography)	N/A
Completed	`NCT01207752` - The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction	N/A
Completed	`NCT05162261` - to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction	N/A
Recruiting	`NCT06064071` - Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD	N/A
Completed	`NCT03652051` - A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)	Phase 2
Recruiting	`NCT03767530` - Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction	N/A
Active, not recruiting	`NCT05577910` - Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD	N/A
Completed	`NCT04889950` - Clinical Study to Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction	N/A
Recruiting	`NCT06004895` - Mechanisms of Light-based Therapies for Dry Eye Disease	N/A
Completed	`NCT04147962` - Intense Pulsed Light in Meibomian Gland Dysfunctions
Completed	`NCT02256969` - Intraductal Meibomian Gland Probing Trial	Phase 4
Recruiting	`NCT05089591` - Intense Pulsed Light in Meibomian Gland Dysfunction	N/A
Completed	`NCT04500821` - Evaluation of the LipiFlow System With a New Activator	N/A
Completed	`NCT03318874` - Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction	Phase 4
Completed	`NCT06278584` - iLux Treatment for Meibomian Gland Dysfunction	N/A
Recruiting	`NCT04052841` - Morphological Analysis of Meibomian Glands	N/A
Completed	`NCT05028491` - The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients